SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-049566
Filing Date
2020-04-22
Accepted
2020-04-22 09:45:29
Documents
4
Period of Report
2020-06-16
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2016073-1_def14a.htm DEF 14A 297967
2 GRAPHIC image_002.gif GRAPHIC 61581
3 GRAPHIC image_003.gif GRAPHIC 24419
4 GRAPHIC n5025_def14a-001.jpg GRAPHIC 7374
  Complete submission text file 0001104659-20-049566.txt   427890
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20713 | Film No.: 20806838
SIC: 2836 Biological Products, (No Diagnostic Substances)